以质量求发展，以服务铸品牌

护理学报 ›› 2023, Vol. 30 ›› Issue (22): 56-62.doi: 10.16460/j.issn1008-9969.2023.22.056

• 循证护理 • 上一篇    下一篇

肺癌中医临床疗效评估工具测量学特性的系统评价

魏佳豪1,2, 卜梦茹1, 白子叶1,2, 周瑾1   

  1. 1.南方医科大学中西医结合医院 护理部,广东 广州 510280;
    2.南方医科大学护理学院,广东 广州 510515
  • 收稿日期:2023-06-28 出版日期:2023-11-25 发布日期:2023-12-07
  • 通讯作者: 周瑾（1977-）,女,安徽巢湖人,博士,主任护师,护理部主任,硕士研究生导师。E-mail:727120567@qq.com
  • 作者简介:魏佳豪（1998-）,男,山西吕梁人,本科学历,硕士研究生在读,护士。
  • 基金资助:
    2022年度广东省中医药局科研项目（20221278）

Measurement property of traditional Chinese medicine clinical effectiveness evaluation scales for lung cancer: a systematic review

WEI Jia-hao1,2, BU Meng-ru1, BAI Zi-ye1,2, ZHOU Jin1   

  1. 1. Dept. of Nursing Administration, Integrated Traditional Chinese and Western Medicine Hospital, Southern Medical University, Guangzhou 510280, China;
    2. School of Nursing, Southern Medical University, Guangzhou 510515, China
  • Received:2023-06-28 Online:2023-11-25 Published:2023-12-07

PDF (PC)

353

赞

摘要： 目的 系统评价肺癌中医临床疗效评估工具的测量学特性和相关研究的方法学质量,为医护人员选择高质量的工具提供循证依据。方法 系统检索PubMed、The Cochrane Library、Web of Science、Embase、PsycINFO、CINAHL、中国生物医学文献数据库、中国知网、万方数据库、维普数据库,检索时限为建库至2023年6月。分别采用基于共识的健康测量工具遴选标准（Consensus-based Standards for the Selection of Health Measurement Instruments,COSMIN）偏倚风险清单和量表测量学性能评价标准评定相关工具的方法学质量及测量属性并形成最终推荐意见。结果 最终纳入8个肺癌中医临床疗效评估工具,均未报告测量误差、跨文化效度或测量等同性。结论 现有证据提示肺癌中医临床疗效评估工具测量学特性评价不够全面,总体研究方法学质量偏低,其中基于中医理论的恶性肿瘤生活质量评价体系之肺癌量表（Quality of Life Assessment System for Cancer based on Traditional Chinese Medicine- Lung Cancer,QLASTCM -Lu）研究质量及性能评价尚可,未来应进一步完善和验证现有工具,或重新构建低偏倚风险、高适用性的肺癌中医临床疗效测量工具。

关键词: 肺癌, 中医, 评估工具, 测量学特性, 系统评价

Abstract: Objective To systematically evaluate the measurement properties of TCM clinical efficacy assessment tools for lung cancer and the methodological quality of related studies, and to provide evidence-based reference for healthcare professionals to select high-quality assessment tools. Methods A systematic search was conducted in multiple databases, including PubMed, The Cochrane Library, Web of Science, Embase, PsycINFO, CINAHL, China Biomedical Literature Database, China Knowledge Network, Wanfang Database, and VIP. The retrieval period was from the inception of the databases to June 2023. The methodological quality and measurement properties of the identified tools were assessed using the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN-RoB) and Scale Measurement Performance Evaluation Criteria, respectively. Based on these evaluations, final recommendations were made. Results Eight TCM clinical efficacy evaluation tools for lung cancer were finally included, and no measurement error, cross-cultural validity and measurement equivalence were reported. Conclusion The existing evidence suggests that TCM clinical efficacy evaluation tools for lung cancer could not provide comprehensive assessment, and the overall research methodology quality is low. Relatively, the research quality and performance evaluation of Quality of Life Assessment System for Cancer based on Traditional Chinese Medicine- Lung Cancer (QLASTCM-Lu) is still acceptable. In the future, the existing tools should be further improved and validated, or a new TCM clinical efficacy measurement tool for lung cancer with low-bias risk and high-applicability should be constructed.

Key words: lung cancer, traditional Chinese medicine, assessment tool, measurement property, systematic review

中图分类号: 

  • R473.73
[1] Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI:10.3322/caac.21492.
[2] Wei Z, Chen J, Zuo F, et al.Traditional chinese medicine has great potential as candidate drugs for lung cancer: a review[J]. J Ethnopharmacol, 2023(300): 115748. DOI:10.1016/j.jep.2022.115748.
[3] 李凯, 张俊华, 张明妍, 等.中医药核心指标集(COS-TCM)研究现状[J]. 世界科学技术-中医药现代化, 2021, 23(8): 2556-2562. DOI:10.11842/wst.20210525013.
[4] 于长禾, 孙亚男, 何丽云, 等. 中医普适性生活质量量表的系统评价[J]. 中华中医药杂志, 2016, 31(2): 432-437.
[5] 张艳宏,刘保延,刘志顺,等. PRO与中医临床疗效评价[J]. 中医杂志,2007(8):680-682.DOI:10.13288/j.11-2166/r.2007.08.003.
[6] 包瑜, 张培彤. 原发性支气管肺癌中医证候研究现状评述[J]. 环球中医药, 2022, 15(7): 1273-1279.
[7] Prinsen CAC, Mokkink LB, Bouter LM, et al.COSMIN guideline for systematic reviews of patient-reported outcome measures[J]. Qual Life Res, 2018, 27(5): 1147-1157. DOI:10.1007/s11136-018-1798-3.
[8] Terwee CB, Mokkink LB, Knol DL,et al.Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist[J].Qual Life Res, 2012,21(4):651-657.DOI:10.1007/s11136
-011-9960-1.
[9] Terwee CB, Bot S DM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires[J]. J Clin Epidemiol, 2007, 60(1):34-42.DOI:10.1016/j.jclinepi.2006.03.012.
[10] Terwee CB, Prinsen CAC Chiarotto A, et al.COSMIN methodology for assessing the content validity of PROMs user manual v1.pdf[EB/OL].[2023-06-20]. https://cosmin.nl/wp-content/uploads/COSMIN-methodology-for-content-validity-user-manual-v1.pdf.
[11] McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate?[J]. Qual Life Res, 1995, 4(4):293-307. DOI:10.1007/BF01593882.
[12] 陈祎婷, 沈蓝君, 彭健, 等. 改良版定量系统评价证据分级方法对患者报告结局测量工具的评价[J]. 解放军护理杂志, 2020, 37(10):57-60. DOI:10.3969/j.issn.1008-9993.2020.10.014.
[13] 于莉, 张会永, 王佳楠, 等. 基于患者报告结局的气虚证中医疗效评价量表考评[J]. 上海中医药杂志, 2020, 54(9): 60-64. DOI:10.16305/j.1007-1334.2020.1910103.
[14] 陈玉招. 气虚证自评量表的初步研制及考评[D]. 福州:福建中医药大学, 2016.
[15] Wan C, You S, Quan P, et al. Development and validation of the quality-of-life assessment system for lung cancer based on traditional chinese medicine[J]. Evid Based Complement Alternat Med, 2012(2012): 945910.0. DOI: 10.1155/2012/945910.
[16] Wang TT, He LY, Zhang M, et al.Development of improved version of quality of life assessment instrument for lung cancer patients based on traditional chinese medicine (QLASTCM-Lu)[J]. Chin J Integr Med, 2019, 25(11): 831-836. DOI:10.1007/s11655-018-2991-5.
[17] 刁佳. 中晚期肺癌患者中医生存质量量表(QOL-AL)的研究[D]. 南京:南京中医药大学, 2007.
[18] 张星辉. 肺系病证自评量表的初步研制及考评[D]. 福州:福建中医药大学, 2016.
[19] 杨可鑫. 阴虚证中医疗效评价量表的研制与考评[D]. 沈阳:辽宁中医药大学, 2018.
[20] 熊丽枚. 阴虚证自评量表的初步研制及考评[D]. 福州:福建中医药大学, 2016.
[21] 施月仙, 张海明, 黄亚琪, 等. 选择健康测量工具的共识标准(COSMIN)偏倚风险评价清单的解读[J]. 中国护理管理,2021,21(7):1053-1057.DOI:10.3969/j.issn.1672-1756.2021.07.018.
[22] Terwee CB, Prinsen Ca.C, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study[J]. Qual Life Res, 2018, 27(5): 1159-1170. DOI:10.1007/s11136-018-1829-0.
[23] 陈祎婷, 彭健, 沈蓝君, 等. COSMIN方法介绍:结合一项系统评价实例进行解读[J].护理研究, 2021, 35(9): 1505-1510. DOI:10.12102/j.issn.1009-6493.2021.09.001.
[24] 徐孟娇, 金潇, 袁文雯, 等. 基于贝叶斯网络与关联规则探讨下肢动脉硬化闭塞症的中医临床疗效评价条目[J]. 中医杂志, 2023, 64(12):1218-1224. DOI:10.13288/j.11-2166/r.2023.12.007.
[25] 王寅, 吴朝旭, 王玥, 等. 基于现代医学诊疗模式的非小细胞肺癌中医证型梳理与浅析[J]. 天津中医药, 2020, 37(10): 1195-1200. DOI:10.11656/j.issn.1672-1519.2020.10.25.
[26] 张成果, 孙小玲, 卢山, 等. 患者重症监护体验测量工具的范围综述[J]. 护理学报, 2022, 29(18): 53-58.DOI:10.16460/j.issn1008-9969.2022.18.053.
[27] 彭健, 沈蓝君, 陈祎婷, 等. 对COSMIN-RoB清单中测量工具稳定性、测量误差和效标效度研究偏倚风险的清单解读[J]. 中国循证医学杂志, 2020, 20(11): 1340-1344.
[28] Moreira RSL, Bassolli L, Coutinho E, et al.Reproducibility and reliability of the quality of life questionnaire in patients with atrial fibrillation[J]. Arq Bras Cardiol, 2016, 106(3): 171-181. DOI: 10.5935/abc.20160026.
[29] Health measurement scales: a practical guide to their development and use(5th edition)[J].Aust N Z J Public Health, 2016, 40(3): 294-295. DOI:10.1111/1753-6405.12484.
[30] 高云, 赵俊峰, 徐丽丽, 等. COSMIN 操作指南对中文版电子健康素养量表的评价[J]. 中国老年学杂志, 2020, 40(9): 1968-1973.
[31] 茅范贞, 韩耀风, 方亚. 量表条目的统计学筛选方法研究进展[J]. 现代预防医学, 2015, 42(1): 1-3.
[32] Edelen MO, Reeve BB.Applying item response theory (IRT) modeling to questionnaire development, evaluation,refinement[J]. Qual Life Res, 2007, 16 Suppl 1(1): 5-18. DOI: 10.1007/s11136-007-9198-0.
[33] Mokkink LB, de Vet HCW, Prinsen Ca.C, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures[J]. Qual Life Res, 2018, 27(5): 1171-1179. DOI:10.1007/s11136-017-1765-4.
[1] 杜易梅, 刘莉, 郭立丽, 卢吉, 付苗苗, 刘杰. 妇科恶性肿瘤患者性健康研究进展[J]. 护理学报, 2025, 32(4): 28-33.
[2] 李垚, 陈小敏, 夏敏, 吴茜, 张琳, 陈叡喆, 葛莉丽, 吴逸梅. 肿瘤患者衰弱评估工具应用的范围综述[J]. 护理学报, 2025, 32(4): 48-52.
[3] 伍丽华, 吴心雨, 赖湘瑜, 邓宝贵, 黄泽青, 赵耀, 廖源, 沈彩萍, 李瑜. 人工关节置换术后患者深静脉血栓风险预测模型的系统评价[J]. 护理学报, 2025, 32(3): 12-16.
[4] 陈恩琳, 莫丰菱, 庄泽明, 张明哲, 周佳坤, 黄丽芳, 纪龙飞, 张莉芳. 脑卒中单侧空间忽略评估工具的范围综述[J]. 护理学报, 2025, 32(3): 43-49.
[5] 李嘉琪, 莫文娟, 王一棋, 王洁, 李梦楠, 刘兴, 冯佳. 基于COSMIN方法对慢性疼痛患者恐动症坦帕评分表的系统评价[J]. 护理学报, 2025, 32(2): 56-62.
[6] 李丁丁, 王帅有, 朱杉杉, 郭鑫, 张会敏, 王宏茹, 潘勤. 脑卒中患者支持性照护需求评估工具的范围综述[J]. 护理学报, 2024, 31(9): 48-53.
[7] 余璐, 黄晓沁, 刘琳, 袁嘉敏, 邬青. 心力衰竭患者30天非计划性再入院风险预测模型的系统评价[J]. 护理学报, 2024, 31(8): 43-48.
[8] 周越, 张杰, 潘宇帆, 戴雨, 孙羽健, 肖益, 余雨枫. 机械通气患者衰弱风险预测模型的系统评价[J]. 护理学报, 2024, 31(6): 56-61.
[9] 吴林梅, 梁志金, 刘瑞杰, 钟静静, 邱予骅. COPD患者运动康复促进和阻碍因素的系统评价-基于CFIR多层次理论[J]. 护理学报, 2024, 31(5): 44-49.
[10] 谭如意, 龙秀红, 马红利, 陈兰. 腰椎间盘突出症患者中医康复健康信息获取行为量表的编制及信效度检验[J]. 护理学报, 2024, 31(5): 67-72.
[11] 魏佳豪, 卜梦茹, 白子叶, 刘恩情, 周瑾. 巳时督灸联合循经推拿对气阴两虚型肺癌患者化疗后癌因性疲乏的影响[J]. 护理学报, 2024, 31(4): 12-16.
[12] 王薇, 周演铃, 薛文萍, 张淋淋, 林书球. 老年髋部骨折患者衰弱评估工具的范围综述[J]. 护理学报, 2024, 31(4): 42-47.
[13] 李佳萍, 朱云霞, 朱宇. 乳腺癌化疗患者症状群的范围综述[J]. 护理学报, 2024, 31(4): 60-64.
[14] 蔡佳佳, 施忠英, 黄楚贤. 进食障碍患者情绪调节评估工具的研究进展[J]. 护理学报, 2024, 31(3): 41-45.
[15] 王丽云, 张明慧, 张新月, 沙凯辉. 产后压力性尿失禁风险预测模型的系统评价[J]. 护理学报, 2024, 31(3): 57-62.
Viewed
Full text


Abstract

Cited
  Shared   
No Suggested Reading articles found!